Rare cancer drugs budget underspent by nearly half
Only 56 per cent of the money allocated for cancer drugs normally unavailable on the NHS was spent in the first six months of a high profile fund, a report has found.
Continue reading this article – simply subscribe below
Subscribing takes two minutes and you’ll immediately have full access to hsj.co.uk, plus the HSJ magazine delivered every week.
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not yet a subscriber?
Sign up today for immediate access to hsj.co.uk and Health Service Journal magazine
Alternatively, try our 14-day free trial subscription
